Signaturefd, LLC Aerie Pharmaceuticals Inc Transaction History

Signaturefd, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$6.37 - $15.23 $2,516 - $6,015	395 New	395 $6,000
Q2 2022 Aug 10, 2022	SELL	$4.95 - $9.16 $697 - $1,291	-141 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$5.64 - $9.8 $795 - $1,381	141 New	141 $1,000
Q4 2021 Jan 25, 2022	SELL	$7.02 - $13.33 $470 - $893	-67 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$11.32 - $16.63 $996 - $1,463	-88 Reduced 56.77%	67 $1,000
Q2 2021 Jul 26, 2021	BUY	$15.16 - $18.97 $2,349 - $2,940	155 New	155 $2,000
Q3 2019 Oct 16, 2019	SELL	$18.41 - $28.0 $2,301 - $3,500	-125 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $5,981 - $8,806	125 New	125 $8,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.